Simultaneous determination of piracetam and its four impurities by rp-hplc with uv detection

Journal of Chromatographic Science

Volumn 48, Issue 7, 2010, Pages 589-594

  Arayne, M Saeed ^a   Sultana, Najma ^a   Siddiqui, Farhan Ahmed ^a   Mirza, Agha Zeeshan ^a   Qureshi, Faiza ^a   Zuberi, M Hashim ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955759541     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.7.589     Document Type: Article

References (25)

1. B. Winblad. A Review of Pharmacological Properties and Clinical Uses. CNS Drug Rev. 11(2): 169-182 (2005).
2. S. Shorvon. Pyrrolidone derivatives. Lancet 358(9296): 1885-1892 (2001).
3. British Pharmacopoeia 2007, Copyright 2006. Published by The stationary office on behalf of the medicines and healthcare products Regulatory Agency (MHRA), pp. 1665.
4. H. Nowell andS.L. Price. Validation of a search technique for crystal structure prediction of flexible molecules by application to piracetam. Acta Crystallogr. B 61(5): 558-568 (2005).
5. J.F. Ovalles, J.N.A. Tettey, J.H. McB Miller, andG.G. Skellern. Determination of piracetam and its impurities by TLC. J. Pharm. Biomed. Anal. 23(4): 757-761 (2000).
6. I. Karamancheva andT. Staneva. Determination of possible impurities in piracetam using FTIR spectroscopy. J. Pharm. Biomed. Anal. 21(6): 1161-1169 (2000).
7. A. El-Gindy, S. Emara, andA. Mostafa. Spectrophotometric and LC determination of two binary mixtures containing antihistamines. Farmaco. 59(9): 713-722 (2004).
8. T. Daldrup, F. Susanto, andP. Michalke. Kombination von DC, GC (OV1 und OV17) und HPLC (RP 18) zur schnellen Erkennung von Artzneimitteln, Rausmitteln und verwandten Verbindungen Fresenius Z. Anal. Chem. 380: 413-427 (1981).
9. W. Rieck andD. Platt. Determination of 2-oxo-pyrrolidine-1- acetamide (piracetam) in human plasma using HPLC. J. Chromatogr. 232: 203-206 (1982).
10. R.M. Nalbandian andM.F. Kubicek. Liquid-chromatographic quantification of Piracetam. Clin. Chem. 29(4): 664-666 (1983).
11. K. Louchahi,M. Tod, P. Bonnardel, andO. Petitjean. Determination of piracetamin human plasma and urine by liquid chromatography. J. Chromatogr. B 663: 385-389 (1995).
12. M.H. Doheny, M.T. O'Connell, andP.N. Patsalos. A high-performance liquid-chromatographic microanalytical procedure for the rapid estimation of Piracetam in plasma or cerebrospinal fluid. J. Pharm. Pharmacol. 48: 514-516 (1996).
13. G. Lunn. HPLC Methods for Pharmaceutical Analysis vol. 2-4, John Wiley and Sons Inc., New York (2000), pp. 349-350.
14. H. Bockhard, H. Oelschlager, andR. Pooth. Rasche dunnschichtdensitometrische Bestimmung des Nootropikums Piracetamin biologischem Material [Fast detection of the nootropic drug piracetam in biological fluids]. Pharmazie. 52: 357-361 (1997).
15. Y. Gaillard andG. Pepin. Use of high-performance liquid chromatography with photodiode-array UV detection for the creation of a 600-compound library. Application to forensic toxicology. J. Chromatogr. A. 763: 149-163 (1997).
16. Z.K. Shihabi, K.Oles, andM. Hinsdale. Analysis of the antiepileptic drug keppra by capillary electrophoresis. J. Chromatogr. A 1004(1-2): 9-12 (2003).
17. H.H. Yeh, Y.H. Yang, J.Y. Ko, andS.H. Chen. Rapid determination of piracetam in human plasma and cerebrospinal fluid by micellar electrokinetic chromatography with sample direct injection. J. Chromatogr. A 1120(1-2): 27-34 (2006).
18. H. Mascher andC. Kikuta. Rapid method for the sensitive determination of Piracetam in plasma by HPLC. J. Pharm. Biomed. Anal. 7(7): 913-916 (1989).
19. Guidance for Industry, Bioanalytical Method Validation, U.S. Dept. of Health and Human Services, Food and Drug Administration, Federal Register 66(100) 2001.
20. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, The European Agency for the Evaluation of Medicinal Products, Committee for ProprietaryMedicinal Products, CPMP/EWP/QWP/1401/98, 2001.
21. OECD, The applications of the GLP principles to short term studies, GLP Consenses Document, Environ. Monogram 99 (1999) (23).
22. D.C. Harris, Análise Química Quantitativa (5th ed.), Livros Técnicos Científicos, Rio de Janeiro (2001), pp. 81-95.
23. OfficialMethods of Analysis, vol. 1, 17th ed., Association ofOfficial Analytical Chemists, AOAC International, Gaithersburg, 2002, p. xx.
24. ICH Topic Q2(R1): Validation of Analytical Procedures: Text and Methodology, 2005.
25. (FDA 94)CDER, (1994), Reviewer Guidance for Validation of Chromotographic Methods, Center of Drug Evaluation and Research - FDA